跳至主要内容
临床试验/NCT04364295
NCT04364295Enrolling By Invitation不适用

Evaluating Real-World Spine Outcomes for Spinal and Orthobiologics Products From Around the World

SeaSpine, Inc.2 个研究点 分布在 1 个国家目标入组 2,285 人开始时间: 2020年3月20日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
2,285
试验地点
2
主要终点
Evaluation of product failure

研究概览

简要总结

A global, prospective, non-randomized, multicenter, observational, post-market, medical record review registry evaluating real-world evidence for SeaSpine products.

详细描述

To gain observational, prospective, real-world clinical, and radiographic data in order to evaluate continued safety and performance following the implantation of SeaSpine products.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Have been treated with at least one SeaSpine product.
  • Have obtained radiographic imaging, as part of the standard of care, at the following time points: preoperative and postoperative.
  • Have obtained at least one preoperative patient-reported outcome measure, as part of the standard of care.
  • Patient is planned, per standard of care, to be assessed with radiographic imaging and consistent patient-reported outcome measure(s) from preoperative through at least two scheduled follow-up visits.

排除标准

  • Was not implanted with at least one SeaSpine product during operation
  • Any other condition that the Investigator determines is unacceptable for enrollment into this registry

结局指标

主要结局

Evaluation of product failure

时间窗: 12 months post-operative

Product failure is defined as product fracture, loosening, gross migration and/or dissociation.

次要结局

  • Incidence of product-related Serious Adverse Events (SAEs) related to the spine, fusion or bone healing, and intraoperative and postoperative unanticipated adverse device effects(Intra-operative to 24 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验